4//SEC Filing
Kendall Keith J 4
Accession 0001214659-20-006104
CIK 0001398733other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:00 PM ET
Size
8.8 KB
Accession
0001214659-20-006104
Insider Transaction Report
Form 4
Kendall Keith J
DirectorCEO and President
Transactions
- Tax Payment
Common Stock
2020-06-30$4.86/sh−148$719→ 639,149 total - Exercise/Conversion
Restricted Stock Units
2020-06-30−333→ 0 totalExercise: $0.00From: 2020-06-30→ Common Stock (333 underlying) - Exercise/Conversion
Common Stock
2020-06-30+333→ 639,297 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F3]There are no expiration dates on RSUs.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001406834
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:00 PM ET
- Size
- 8.8 KB